tiprankstipranks
Trending News
More News >
Sinovac Biotech (SVA)
NASDAQ:SVA
US Market

Sinovac Biotech (SVA) Income Statement

Compare
136 Followers

Sinovac Biotech Income Statement

Last quarter (Q1 2024), Sinovac Biotech's total revenue was $307.87M, a decrease of -96.33% from the same quarter last year. In Q1, Sinovac Biotech's net income was $-116.84M. See Sinovac Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 448.27M$ 1.49B$ 19.37B$ 510.62M$ 246.05M
Gross Profit
$ 266.75M$ 808.30M$ 18.30B$ 443.44M$ 213.58M
Operating Expenses
$ 813.48M$ 1.27B$ 748.45M$ 227.64M$ 144.73M
Depreciation and Amortization
$ 144.75M$ 156.60M$ 100.43M$ 6.63M$ 8.02M
EBITDA
$ -6.03M$ 183.10M$ 17.65B$ 221.76M$ 76.05M
Operating Income
$ -546.72M$ -466.07M$ 17.55B$ 215.64M$ 68.56M
Other Income/Expenses
$ 393.69M$ 491.31M$ 9.78M$ 973.00K$ 2.26M
Pretax Income
$ -153.03M$ 25.24M$ 17.56B$ 216.62M$ 70.82M
Net Income
$ -99.92M$ 113.87M$ 8.47B$ 110.37M$ 44.93M
Per Share Metrics
Basic EPS
$ -1.06$ 1.08$ 85.20$ 1.06$ 0.42
Diluted EPS
$ -1.06$ 1.00$ 74.27$ 0.97$ 0.41
Weighted Average Shares Outstanding
99.61M 99.50M 99.31M 98.90M 94.88M
Weighted Average Shares Outstanding (Diluted)
99.61M 114.17M 114.01M 113.66M 109.69M
Currency in USD

Sinovac Biotech Earnings and Revenue History